Optimal Dosage of Caspofungin in Critically Ill Patients

NCT01994096 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Critically Ill
Suspected Invasive Candidiasis

Interventions

DRUG: Caspofungin

Sponsor

University Medical Center Groningen